Do\u00e7. Dr. Hakan Yabano\u011flu, \u00fclkede en s\u0131k rastlanan hipertiroidi nedenlerinden biri olan \u2019Graves\u2019 hastal\u0131\u011f\u0131n\u0131n halk aras\u0131nda s\u0131k\u00e7a \u2018zehirli guatr\u2019 olarak da bilindi\u011fini belirterek, \u201cGraves hastal\u0131\u011f\u0131na a\u011f\u0131r stresler, kazalar, hastal\u0131klar ve baz\u0131 ila\u00e7lar neden olabilir ama bunlar\u0131n d\u0131\u015f\u0131nda genetik yatk\u0131nl\u0131\u011f\u0131n Graves hastal\u0131\u011f\u0131n\u0131n g\u00f6r\u00fclmesinde en \u00f6nemli fakt\u00f6rlerden biridir\u201d dedi.<\/p>\n
Graves hastal\u0131\u011f\u0131 do\u011fal ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin tetikledi\u011fi bir hipertiroidi (zehirli guatr) hastal\u0131\u011f\u0131 oldu\u011funu belirten Ba\u015fkent \u00dcniversitesi Adana Dr. Turgut Noyan Uygulama ve Ara\u015ft\u0131rma Merkezi Genel Cerrahi Ana Bilim Dal\u0131 Do\u00e7. Dr. Hakan Yabano\u011flu, \u201cBa\u011f\u0131\u015f\u0131kl\u0131k sistemine ait h\u00fccrelerin sa\u011fl\u0131kl\u0131 tiroit h\u00fccrelerine sald\u0131rmas\u0131 sonucu tiroid bezinden \u00e7ok fazla miktarda tiroid hormonu kana ge\u00e7er ve hipertiroidi tablosunun olu\u015fmas\u0131na neden olur. T\u00fcm hipertiroidi vakalar\u0131n\u0131n y\u00fczde 50-80\u2019de altta yatan neden Graves hastal\u0131\u011f\u0131d\u0131r. Genellikle 20-40 ya\u015f aral\u0131\u011f\u0131nda ve kad\u0131nlarda erkeklerden 5-7 kat daha fazla g\u00f6r\u00fclmektedir. Genetik yatk\u0131nl\u0131\u011f\u0131n Graves hastal\u0131\u011f\u0131n\u0131n g\u00f6r\u00fclmesinde en \u00f6nemli fakt\u00f6rlerden biri oldu\u011fu d\u00fc\u015f\u00fcn\u00fclmektedir. Bu nedenle ailesinde Graves hastal\u0131\u011f\u0131 olan bireylerde hastal\u0131\u011f\u0131n g\u00f6r\u00fclme riski artmaktad\u0131r. Ayr\u0131ca stres, \u00fcz\u00fcnt\u00fc, sigara i\u00e7ilmesi, iyot i\u00e7eren besinlerden fazla t\u00fcketmek ve baz\u0131 ila\u00e7lar bu hastal\u0131\u011f\u0131n olu\u015fumuna neden olabilmektedir\u201d diye konu\u015ftu.<\/p>\n
Graves hastal\u0131\u011f\u0131n\u0131n ki\u015fide bir\u00e7ok belirtisinin olabilece\u011fine de\u011finen Do\u00e7. Dr. Yabano\u011flu s\u00f6zlerine \u015f\u00f6yle devam etti:<\/p>\n
\u201cBu hastal\u0131\u011f\u0131n ilk belirtilerinde \u00e7arp\u0131nt\u0131, terleme, ellerde titreme, i\u015ftah\u0131n artmas\u0131na ra\u011fmen zehirli guatra ba\u011fl\u0131 kilo kayb\u0131, adet d\u00fczensizli\u011fi, s\u0131ca\u011fa tahamm\u00fcls\u00fczl\u00fck, sa\u00e7larda d\u00f6k\u00fclme, cildin terli ve nemli olmas\u0131, ishal, g\u00f6z ka\u015f\u0131nmas\u0131 ve sulanmas\u0131, yorgunluk, uykusuzluk gibi \u015fikayetler g\u00f6r\u00fclebilmektedir. Bu \u015fikayetleri olan hastalar\u0131n olas\u0131 hipertiroidi veya Graves hastal\u0131\u011f\u0131 i\u00e7in endokrinoloji veya genel cerrahi kliniklerine ba\u015fvurmalar\u0131 gerekmektedir. Hastalara yap\u0131lan laboratuvar incelemelerinde tiroid hormonlar\u0131n\u0131n y\u00fcksek ve TSH hormonunun d\u00fc\u015f\u00fck oldu\u011fu g\u00f6r\u00fclmektedir.\u201d<\/p>\n
“Tedavi se\u00e7iminde hastaya ve hastal\u0131\u011fa ait unsurlar belirleyicidir”<\/p>\n
Graves hastal\u0131\u011f\u0131n\u0131n g\u00fcn\u00fcm\u00fczde \u00fc\u00e7 farkl\u0131 y\u00f6ntem ile tedavi edildi\u011fini s\u00f6yleyen Do\u00e7. Dr. Yabano\u011flu, \u201cBu hastal\u0131\u011f\u0131n tedavisinde antitiroit ila\u00e7, radyoaktif iyot tedavisi ve cerrahi tedavi olmak \u00fczere \u00fc\u00e7 farkl\u0131 y\u00f6ntem vard\u0131r. Hastalarda tedavi plan\u0131 yap\u0131l\u0131rken ki\u015fiye \u00f6zg\u00fc bireysel de\u011ferlendirme yap\u0131lmal\u0131 ve tedavideki \u00f6ncelik s\u0131ras\u0131 buna g\u00f6re belirlenmelidir. \u00c7\u00fcnk\u00fc her 3 tedavi y\u00f6nteminin olumlu ya da olumsuz taraflar\u0131 vard\u0131r. Tedavi se\u00e7iminde hastaya ve hastal\u0131\u011fa ait (ya\u015f, cinsiyeti, gebelik, emzirme, e\u015flik eden di\u011fer tiroid hastal\u0131klar\u0131, aile \u00f6yk\u00fcs\u00fc, hasta uyumu, hastal\u0131\u011f\u0131n \u015fiddeti, tiroit bezinin b\u00fcy\u00fckl\u00fc\u011f\u00fc, g\u00f6z bulgular\u0131) unsurlar belirleyicidir.\u201d dedi.<\/p>\n
Cerrahi tedavi genellikle Antitiroid ila\u00e7 ve Radyoaktif iyot tedavisi almaya engel bir durum oldu\u011funda veya k\u0131sa s\u00fcrede etkin tedavinin sa\u011flanmas\u0131 planland\u0131\u011f\u0131nda tercih edildi\u011fini belirten Do\u00e7. Dr. Yabano\u011flu, s\u00f6zlerini \u015f\u00f6yle tamamlad\u0131:<\/p>\n
\u201cUygun \u015fekilde cerrahi tedavi yap\u0131lan olgularda n\u00fcks olas\u0131l\u0131\u011f\u0131 olduk\u00e7a d\u00fc\u015f\u00fck iken Antitiroid ila\u00e7 ve Radyoaktif iyot tedavisi ile n\u00fcks oranlar\u0131 y\u00fczde 40-50 civar\u0131ndad\u0131r. Graves hastal\u0131\u011f\u0131nda cerrahi tedavi \u00f6zellikle b\u00fcy\u00fck guatr veya kan\u0131tlanm\u0131\u015f ya da \u015f\u00fcpheli kanser, ciddi g\u00f6z bulgular\u0131 Antitiroid ila\u00e7 ve Radyoaktif iyot tedavi almaya engel durumlar\u0131n varl\u0131\u011f\u0131nda tercih edilmelidir. Graves hastal\u0131\u011f\u0131nda genellikle tiroid bezi homojen olarak b\u00fcy\u00fcmektedir. Ancak baz\u0131 hastalarda Graves hastal\u0131\u011f\u0131na nod\u00fclleride e\u015flik edebilmektedir. Bu hasta gruplar\u0131nda kanser g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131 son d\u00f6nem k\u0131lavuzda y\u00fczde 2 iken, yap\u0131lan son \u00e7al\u0131\u015fmalarda ve bizimde klinik deneyimlerimiz ile bu oran\u0131n artt\u0131\u011f\u0131 g\u00f6rmekteyiz. Bu nedenle \u00f6zellikle nod\u00fcllerin e\u015flik etti\u011fi, aile hikayesi olan hastalarda cerrahi daha \u00f6n planda de\u011ferlendirilmelidir.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"
BA\u015eKENT \u00dcN\u0130VERS\u0130TES\u0130 ADANA DR. TURGUT NOYAN UYGULAMA VE ARA\u015eTIRMA MERKEZ\u0130 GENEL CERRAH\u0130 ANA B\u0130L\u0130M DALI DO\u00c7. DR. HAKAN YABANO\u011eLU, \u00dcLKEDE EN SIK RASTLANAN H\u0130PERT\u0130RO\u0130D\u0130 NEDENLER\u0130NDEN B\u0130R\u0130 OLAN GRAVES HASTALI\u011eININ HALK ARASINDA SIK\u00c7A \u2018ZEH\u0130RL\u0130 GUATR\u2019 OLARAK DA B\u0130L\u0130ND\u0130\u011e\u0130N\u0130 BEL\u0130RTEREK, GRAVES HASTALI\u011eINA A\u011eIR STRESLER, KAZALAR, HASTALIKLAR VE BAZI \u0130LA\u00c7LARIN NEDEN OLAB\u0130LECE\u011e\u0130N\u0130 S\u00d6YLED\u0130.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,20],"tags":[109975,26192,36994,12658,12653,14063],"class_list":["post-1372483","post","type-post","status-publish","format-standard","hentry","category-saglik","category-turkiye","tag-graves","tag-gorulen","tag-guatr","tag-sik","tag-turu","tag-zehirli"],"_links":{"self":[{"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=\/wp\/v2\/posts\/1372483","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1372483"}],"version-history":[{"count":0,"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=\/wp\/v2\/posts\/1372483\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1372483"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1372483"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1372483"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}